Cell-Based Flu Antigen to Be Incorporated in DelSite's Nasal Vaccine Product DelSite is developing a nasal powder vaccine for pandemic avian influenza that combines its proprietary GelVac(TM) vaccine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback